Dr Martine Keenan
Head of Drug Discovery
Infectious Diseases
Epichem
Australia
Biography
Martine is a medicinal chemist with 10 years professional experience in drug discovery, including 8 years in a multinational pharmaceutical company. Following a PhD in natural products synthesis at Kings' College in London, and post-doctoral studies in Germany developing chiral catalysts for asymmetric hydrogenation, Martine took up a medicinal chemistry position in the neuroscience division of Eli Lilly in the UK. Martine has expertise in identifying novel hits, designing new analogues, computer-aided drug design, using SAR analysis to develop compounds into new leads and optimising molecules towards drug candidates. Martine moved to Perth, Australia and joined Epichem in 2008 working primarily in the field of infectious diseases, and managing drug discovery projects.
Research Interest
Martine is a medicinal chemist with 10 years professional experience in drug discovery, including 8 years in a multinational pharmaceutical company. Following a PhD in natural products synthesis at Kings' College in London, and post-doctoral studies in Germany developing chiral catalysts for asymmetric hydrogenation, Martine took up a medicinal chemistry position in the neuroscience division of Eli Lilly in the UK. Martine has expertise in identifying novel hits, designing new analogues, computer-aided drug design, using SAR analysis to develop compounds into new leads and optimising molecules towards drug candidates. Martine moved to Perth, Australia and joined Epichem in 2008 working primarily in the field of infectious diseases, and managing drug discovery projects.
